These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7357547)

  • 1. An in vitro and in vivo investigation of three surface-active agents as modulators of cell proliferation.
    Tobler J; Watts MT; Fu JJ
    Cancer Res; 1980 Apr; 40(4):1173-80. PubMed ID: 7357547
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of 24R,25-dihydroxyvitamin D3.
    Maeda Y; Hirai T; Yamato H; Kobori N; Matsunaga K; Oguchi Y; Yoshimura M; Fujii T; Kobayashi Y; Saitoh K
    In Vivo; 1988; 2(2):129-32. PubMed ID: 2979828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term sublytic uptake of ammonio carboxylate surfactants by cultured hamster embryo fibroblasts.
    Watts MT; Roggenkamp JG
    Anal Biochem; 1980 Sep; 107(2):436-42. PubMed ID: 7435973
    [No Abstract]   [Full Text] [Related]  

  • 5. A potent inhibitor of normal and transformed cell growth derived from contact-inhibited cells.
    Lipkin G; Knecht ME; Rosenberg M
    Cancer Res; 1978 Mar; 38(3):635-43. PubMed ID: 626968
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ministry of Education Group on Special Comprehensive Cancer Study: Report by the special committee on antineoplastic agent screening].
    Gan To Kagaku Ryoho; 1987 Jan; 14(1 Pt 2):227-361. PubMed ID: 3813570
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-kill kinetics of several S-phase-specific drugs.
    Bhuyan BK; Fraser TJ; Gray LG; Kuentzel SL; Neil GL
    Cancer Res; 1973 Apr; 33(4):888-94. PubMed ID: 4735241
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological activity of macrocyclic taxane analogues.
    Tarrant JG; Cook D; Fairchild C; Kadow JF; Long BH; Rose WC; Vyas D
    Bioorg Med Chem Lett; 2004 May; 14(10):2555-8. PubMed ID: 15109650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic transformation of Syrian hamster epidermal cells in vitro.
    Sina JF; Bradley MO; O'Brien TG
    Cancer Res; 1982 Oct; 42(10):4116-23. PubMed ID: 7105008
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of urethan induced lung tumour growth in strain A mice by 5-methyl cytidine.
    Theiss JC
    Cytobios; 1980; 29(115-116):159-63. PubMed ID: 7471817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoplasms, originating from cells transformed in vitro, in isologous and heterologous organisms].
    Kuz'mina SV; Kalinina LI
    Vopr Onkol; 1971; 17(11):59-62. PubMed ID: 5157640
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoregulin.
    Evans CH
    Prog Clin Biol Res; 1989; 288():259-70. PubMed ID: 2654952
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
    Yoshida N; Kiyohara T; Fukui M; Atsumi T; Ogino S; Inaba M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1980 Oct; 40(10):3810-4. PubMed ID: 7438064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of surface immunoglobulin capping on mouse splenic lymphocytes by cetyltrimethylammonium bromide.
    Paatero GI; Brown DL; Waterhouse PD
    Cell Mol Biol; 1986; 32(1):79-85. PubMed ID: 3948207
    [No Abstract]   [Full Text] [Related]  

  • 18. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.